These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 28387755

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Serotonin (5-HT) inhibits Factor XIII-A-mediated plasma fibronectin matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation.
    Cui C, Kaartinen MT.
    Bone; 2015 Mar; 72():43-52. PubMed ID: 25460579
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss.
    Yu W, Zhong L, Yao L, Wei Y, Gui T, Li Z, Kim H, Holdreith N, Jiang X, Tong W, Dyment N, Liu XS, Yang S, Choi Y, Ahn J, Qin L.
    J Clin Invest; 2021 Jan 19; 131(2):. PubMed ID: 33206630
    [Abstract] [Full Text] [Related]

  • 26. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
    Al-Jallad HF, Nakano Y, Chen JL, McMillan E, Lefebvre C, Kaartinen MT.
    Matrix Biol; 2006 Apr 19; 25(3):135-48. PubMed ID: 16469487
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency.
    Griffin KJ, Newell LM, Simpson KR, Beckers CML, Drinkhill MJ, Standeven KF, Cheah LT, Iismaa SE, Grant PJ, Jackson CL, Pease RJ.
    Atherosclerosis; 2020 Feb 19; 294():1-9. PubMed ID: 31874419
    [Abstract] [Full Text] [Related]

  • 30. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue.
    Alwood JS, Shahnazari M, Chicana B, Schreurs AS, Kumar A, Bartolini A, Shirazi-Fard Y, Globus RK.
    J Interferon Cytokine Res; 2015 Jun 19; 35(6):480-7. PubMed ID: 25734366
    [Abstract] [Full Text] [Related]

  • 31. Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.
    Cordell PA, Newell LM, Standeven KF, Adamson PJ, Simpson KR, Smith KA, Jackson CL, Grant PJ, Pease RJ.
    Matrix Biol; 2015 Apr 19; 43():85-96. PubMed ID: 25680676
    [Abstract] [Full Text] [Related]

  • 32. Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
    Zhao D, Shu B, Wang C, Zhao Y, Cheng W, Sha N, Li C, Wang Q, Lu S, Wang Y.
    J Cell Biochem; 2020 Jan 19; 121(1):152-164. PubMed ID: 31318102
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.
    Bone; 1999 Nov 19; 25(5):517-23. PubMed ID: 10574571
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. TM9SF4 is a novel regulator in lineage commitment of bone marrow mesenchymal stem cells to either osteoblasts or adipocytes.
    Yu L, Xie M, Zhang F, Wan C, Yao X.
    Stem Cell Res Ther; 2021 Nov 13; 12(1):573. PubMed ID: 34774100
    [Abstract] [Full Text] [Related]

  • 38. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
    Dela Cruz A, Grynpas MD, Mitchell J.
    Am J Physiol Endocrinol Metab; 2016 May 15; 310(10):E811-20. PubMed ID: 27006198
    [Abstract] [Full Text] [Related]

  • 39. Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.
    Koskinen C, Persson E, Baldock P, Stenberg Å, Boström I, Matozaki T, Oldenborg PA, Lundberg P.
    J Biol Chem; 2013 Oct 11; 288(41):29333-44. PubMed ID: 23990469
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.